VEGFA and gastric neoplasm: Simultaneous target of VEGF and CD47 significantly improved anti-tumor efficacy and inhibiting tumour metastasis in gastric tumour-bearing mice, which was most likely mediated through facilitating enhanced macrophage infiltration, confirmed synergistic anti-tumor effect following combined treatment with bevacizumab and anti-CD47 antibody.